← Back to Search

Active Life for Chronic Obstructive Pulmonary Disease (ActiveCOPD Trial)

N/A
Waitlist Available
Led By Janet L Larson, PhD
Research Sponsored by University of Michigan
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up measured at baseline, end of 10 week intervention and at 3, 6, and 12 months after the completion of the 10 week intervention
Awards & highlights

ActiveCOPD Trial Summary

This trial looks at whether a lifestyle and exercise program can help people with chronic obstructive pulmonary disease be more active. If successful, the program could be used to improve the health of people with COPD.

Eligible Conditions
  • Chronic Obstructive Pulmonary Disease (COPD)

ActiveCOPD Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~measured at baseline, end of 10 week intervention and at 3, 6, and 12 months after the completion of the 10 week intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and measured at baseline, end of 10 week intervention and at 3, 6, and 12 months after the completion of the 10 week intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Time Spent in Physical Activity as Measured by Upright Time (Minutes Per Day) Monitored by ActivPal Monitor
Time Spent in Sedentary Behavior
Secondary outcome measures
Six-minute Walk Test
Other outcome measures
Barriers Efficacy for Physical Activity Scale: Chronic Obstructive Pulmonary Disease
Chronic Respiratory Questionnaire Dyspnea Scale
Multidimensional Outcomes Expectations Scale
+5 more

ActiveCOPD Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Active LifeExperimental Treatment1 Intervention
The Active Life intervention includes structured walking, functional circuit training, stretching and behavior/educational components.
Group II: Chair exercisesPlacebo Group1 Intervention
The Chair exercise intervention includes chair exercises, behavioral relaxation and health education.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Active Life
2017
N/A
~190

Find a Location

Who is running the clinical trial?

National Institute of Nursing Research (NINR)NIH
580 Previous Clinical Trials
10,376,382 Total Patients Enrolled
University of MichiganLead Sponsor
1,796 Previous Clinical Trials
6,377,771 Total Patients Enrolled
Janet L Larson, PhDPrincipal InvestigatorUniversity of Michigan
1 Previous Clinical Trials
23 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research endeavor recruiting participants presently?

"Confirmed, recruitment for this trial has concluded. The listing of the clinical research was uploaded to clinicaltrials.gov on July 27th 2017 and last updated March 9th 2022. Fortunately, 477 other trials are still open for applicants at present time."

Answered by AI

What are the objective outcomes this investigation is striving to attain?

"This medical trial will span 10 weeks, with data gathered 7 days after the completion of the intervention and 12 months post-intervention. The primary outcome to be evaluated is Time spent in Physical Activity and sedentary behaviour at the end of treatment. Secondary outcomes involve a Six-minute walk test, Isometric strength (knee flexors and extensors) assessment, as well as PROMIS Physical Function measurements using computer adaptive testing with T-scores calculated based on mean = 50 and standard deviation = 10; lower scores indicate poorer physical function while higher numbers suggest enhanced performance."

Answered by AI

Who else is applying?

What state do they live in?
Michigan
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
clinicaltrials.govStudy
Active for Life: Chronic Obstructive Pulmonary Disease
Janet L. Larson 2017. "Active for Life: Chronic Obstructive Pulmonary Disease". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03201198.
~24 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top